Determining the Cost-Effectiveness of Health Promotion Programs

  • Eli Capilouto
Part of the The Springer Series in Behavioral Psychophysiology and Medicine book series (SSBP)

Abstract

Today, new forms of organizing and delivering health care services are emerging. Managed care arrangements are creating more focus on the cost and consequences of health care services. Under many of these managed care plans, providers receive fixed capitated payments regardless of the magnitude of services consumed. The provider assumes more financial risk and is likely to pay greater attention to the costs and benefits of care in this financing arrangement. The managed care movement is creating more emphasis on populations. These populations can be defined by membership in a particular insured group or by membership in a group at risk for a certain disease. In either case, many contend that providers of care will have more incentive to move beyond the delivery of care at the time of illness to more proactive prevention and health promotion programs for these populations. If so, the costs, savings, and health consequences must be measured and compared to alternative interventions.

Keywords

Cholesterol Transportation Pneumonia Nicotine Assure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acton, P. (1973). Evaluating public programs to save lives: The case of heart attacks. Santa Monica, CA: Rand Corporation (R-950-RC, January).Google Scholar
  2. Bergner, M. (1989). Quality of life, health status, and clinical research. Medical Care, 27, S148–S156.CrossRefPubMedGoogle Scholar
  3. Bosch, J. L., & Hunink, M. G. M. (1996). The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Medical Decision Making, 16, 317–325.CrossRefGoogle Scholar
  4. Boyle, M. H., Torrance, G. W., Sinclair, J. C., & Horwood, S. P. (1983). Economic evaluation of neonatal intensive care of very-low-birth-weight infants. New England Journal of Medicine, 308, 1330–1337.CrossRefPubMedGoogle Scholar
  5. Detsky, A. S., & Naglie, I. G. (1990). A clinician’s guide to cost-effectiveness analysis. Annals of Internal Medicine, 113, 147–154.CrossRefPubMedGoogle Scholar
  6. Doubilet, P., Weinstein, M. C., & McNeil, B. J. (1986) Use and misuse of the term “cost effective” in medicine. New England Journal of Medicine, 314, 253–256.CrossRefPubMedGoogle Scholar
  7. Drummond, M F., Stoddart, G. L., & Torrance, G. W. (1987). Methods for the economic evaluation of health care programmes. Oxford, England: Oxford Medical Publications.Google Scholar
  8. Eddy, D. M. (1990). Screening for cervical cancer. Annals of Internal Medicine, 113, 214–226.CrossRefPubMedGoogle Scholar
  9. Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995). Multi-attribute health status classification systems. PharmacoEconomics, 7(6), 490–502.CrossRefPubMedGoogle Scholar
  10. Feeny, D. H., Torrance, G. W., & Furlong, W. J. (1996). Health utilities index. In B. Spiker (Ed.), Quality of life and pharmacoeconomics in clinical trails (pp. 239–252). Philadelphia: Lippincott-Raven.Google Scholar
  11. Furlong, W., Feeny, D., Torrance, G. W., Barr, R., & Horsman J. (1990, June). Guide to design and development of health-state utility instrumentation. McMaster University Centre for health Economics and Policy Analysis Working paper 90-09, V, 141.Google Scholar
  12. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.Google Scholar
  13. Johannesson, M., Jonsson, B., & Borgquist, L. (1991). Willingness to pay for anti-hypertensive therapy— Results of a Swedish pilot study. Journal of Health Economics, 10(4), 461–473.CrossRefPubMedGoogle Scholar
  14. Kamlet, M. S. (1992). The comparative benefits model. Washington, DC: US Department of Health and Human Services.Google Scholar
  15. Kaplan, R. M. (1995). Utility assessment for estimating quality-adjusted life years. In F. Sloan (Ed.), Valuing health care (pp. 31–60). New York: Cambridge University Press.CrossRefGoogle Scholar
  16. Leutwyler, K. (1995, April). The price of prevention. Scientific American, 124–129.Google Scholar
  17. Mishan, E. J. (1982). Cost-benefit analysis: An informal introduction (4th ed.). London: Unwin Hyman.Google Scholar
  18. Moore M. J., & Viscusi, W. K. (1988). The quantity-adjusted values of life. Economic Inquiry, 26(3), 369–388.CrossRefGoogle Scholar
  19. Olson, C. A. (1981). An analysis of wage differentials received by workers on dangerous jobs. Journal of Human Resources, 16(2), 167–185.CrossRefGoogle Scholar
  20. Pauly, M. V. (1995). Valuing health care benefits in money terms. In F. Sloan (Ed.), Valuing health care (pp. 99–124). New York: Cambridge University Press.CrossRefGoogle Scholar
  21. Pliskin, J. S., Shepard, D. S., & Weinstein, M. C. (1980). Utility function for life years and health status. Operations Research, 28, 206–224.CrossRefGoogle Scholar
  22. Read, J. L., Quinn, R. J., Berwick, D. M., Fineberg, H. V., & Weinstein, M. C. (1984). Preferences for health outcomes. Medical Decision Making, 4(3), 315–329.CrossRefPubMedGoogle Scholar
  23. Tengs, T. O., Adams, M. E., Pliskin, J. S., Safran, D. G., Siegel, J. E., Weinstein, M. C., & Graham, J. D. (1995). Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis, 15(3), 369–390.CrossRefPubMedGoogle Scholar
  24. Thompson, M. S. (1986). Willingness-to-pay and accept risk to cure chronic disease. American Journal of Public Health, 76(4), 392–396.CrossRefPubMedGoogle Scholar
  25. Torrance, G. W. (1976). Social preferences for health states: an empirical evaluation of three measurement techniques. Socio-Economic Plan Science, 10, 129–136.CrossRefGoogle Scholar
  26. Torrance, G. W., Sackett, D. L., & Thomas. W. H. (1972). A utility maximization model for evaluation of health care programmes. Health Services Research, 7(2), 118–133.PubMedGoogle Scholar
  27. Torrance, G. W., Boyle, M. H., & Horword, S. P. (1982). Application of multi-attribute utility theory to measure social preferences for health states. Operations Research, 30, 1043–1069.CrossRefPubMedGoogle Scholar
  28. Torrance, G. W., Furlong, W., Feeny, D., & Boyle, M. (1995). Multi-attribute preference functions. Pharmaco Economics, 7(6), 490–502.CrossRefGoogle Scholar
  29. Viscusi, W. K. (1979). Employment hazards: an investigation of market performance. Cambridge, MA: Harvard University Press.Google Scholar
  30. von Neuman, J., & Morgenstern, O. (1947). Theories of games and economic behavior. Princeton, NJ: Princeton University Press.Google Scholar
  31. Ware, J. E., & Sherbourne, D.C. (1992). The MOS 36-item short-form health survey. Medical Care, 30, 473–483.CrossRefPubMedGoogle Scholar
  32. Weinstein, M. C. (1995). From cost-effectiveness ratios to resource allocation. In F. Sloan (Ed.), Valuing health care (pp. 99–124). New York: Cambridge University Press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Eli Capilouto
    • 1
  1. 1.Department of Health Care Organization and Policy, School of Public Health, UAB Center for Health PromotionUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations